Vertex Pharmaceuticals Inc (VRTX)
417.50
-0.96
(-0.23%)
USD |
NASDAQ |
Mar 27, 16:00
417.82
+0.32
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals Stock Buybacks (Quarterly): 152.70M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 152.70M |
September 30, 2023 | 170.20M |
June 30, 2023 | 31.40M |
March 31, 2023 | 299.40M |
December 31, 2022 | 2.10M |
September 30, 2022 | 48.00M |
June 30, 2022 | 4.40M |
March 31, 2022 | 117.50M |
December 31, 2021 | 369.90M |
September 30, 2021 | 660.80M |
June 30, 2021 | 3.60M |
March 31, 2021 | 527.00M |
December 31, 2020 | 151.59M |
September 30, 2020 | 148.54M |
June 30, 2020 | 3.08M |
March 31, 2020 | 436.19M |
December 31, 2019 | 36.05M |
September 30, 2019 | 0.104M |
June 30, 2019 | 56.01M |
March 31, 2019 | 99.84M |
December 31, 2018 | 143.00M |
September 30, 2018 | 92.00M |
June 30, 2018 | 105.03M |
March 31, 2018 | 10.00M |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 108.74M |
September 30, 2011 | -20.07M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
0.104M
Minimum
Sep 2019
660.80M
Maximum
Sep 2021
165.92M
Average
108.67M
Median
Stock Buybacks (Quarterly) Benchmarks
Amgen Inc | 0.00 |
Eli Lilly and Co | 0.00 |
Regeneron Pharmaceuticals Inc | 446.10M |
Moderna Inc | 0.00 |
Merck & Co Inc | 393.00M |